New momentum for harmonizing TMB results

Author:

QIAGEN Digital Insights

New momentum for harmonizing TMB results

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across cancer types does not appear to be feasible.

 

Check out this recent article published in Genes, Chromosomes & Cancer on how QIAGEN is collaborating with leading institutions in cancer research and treatment to harmonize TMB estimation and reporting in clinical samples.

 

Read the full article here!